The American Lung Association/COPD Foundation Partnership Research Award in Bronchiectasis represents a funding partnership between the COPD Foundation and the American Lung Association. The award, created in 2006, provides funding for investigators focused on the treatment or cure of bronchiectasis. The award will be for a maximum of $100,000 per year for a two year period.

The American Lung Association/COPD Foundation Partnership Research Award in Bronchiectasis supports translational research on bronchiectasis. Specifically, the program focuses on translating the most promising research findings into approved therapies. Studies on how to halt or reverse the disease progression will be given highest priority, and early detection and prevention grants will also be considered.

The bronchiectasis research opportunities that should be explored include: i) the need to identify clinical and pathological phenotypes of bronchiectasis within various types of lung disease, including bronchiectasis isolated from other forms of lung disease,including factors of genetic disposition; ii) increased understanding of repair processes in airway structural components; iii) possible role of immune system deficiencies in development of bronchiectasis and characterization of the inflammatory process; iv) role of environmental mycobacteria in the pathogenesis of bronchiectasis; v) understanding the clearance of mucus and ciliary activity in bronchial injury and repair; and vi) bacterial flora.

Applicants must be independent, self-directed researchers for whom their institution must provide space and other resources customary for independent investigators. The application must convey the commitment of the institution to the applicant and the proposed research activities.

For more information about the American Lung Association Nationwide Research Program go to https://v2.ramscompany.com.